Cargando…
Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis
Voclosporin, a novel immunomodulatory drug inhibiting the calcineurin enzyme, was developed to prevent organ graft rejection and to treat autoimmune diseases. The chemical structure of voclosporin is similar to that of cyclosporine A, with a difference in one amino acid, leading to superior calcineu...
Autores principales: | Roesel, Martin, Tappeiner, Christoph, Heiligenhaus, Arnd, Heinz, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180504/ https://www.ncbi.nlm.nih.gov/pubmed/21966207 http://dx.doi.org/10.2147/OPTH.S11125 |
Ejemplares similares
-
Voclosporin as a Treatment for Noninfectious Uveitis
por: Schultz, Clyde
Publicado: (2013) -
Protective effect of the novel calcineurin inhibitor voclosporin in experimental colitis
por: Lindemann, Aylin, et al.
Publicado: (2023) -
Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLE
por: van Gelder, Teun, et al.
Publicado: (2021) -
A new agent for the treatment of noninfectious uveitis: rationale and design of three LUMINATE (Lux Uveitis Multicenter Investigation of a New Approach to Treatment) trials of steroid-sparing voclosporin
por: Anglade, Eddy, et al.
Publicado: (2008) -
Occurrence and Risk Factors for Macular Edema in Patients with Juvenile Idiopathic Arthritis-Associated Uveitis
por: Tappeiner, Christoph, et al.
Publicado: (2021)